Extracellular vesicles in cancer nanomedicine
Copyright © 2019 Elsevier Ltd. All rights reserved..
To date, a lot of nanotechnological optitions are available for targeted drug delivery. Extracellular vesicles (EVs) are membrane structures that cells use for storage, transport, communication, and signaling. Recent research has focused on EVs as natural nanoparticles for drug delivery. This review sheds light on the application of EVs in cancer therapy, such as targeted chemotherapy, gene therapy, and vaccine development. Aspects of biogenesis, isolation, targeting, and loading of EVs are discussed in detail.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:69 |
|---|---|
| Enthalten in: |
Seminars in cancer biology - 69(2021) vom: 01. Feb., Seite 212-225 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tarasov, Vadim V [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antineoplastic Agents |
|---|
| Anmerkungen: |
Date Completed 03.03.2022 Date Revised 03.03.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.semcancer.2019.08.017 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM300314949 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM300314949 | ||
| 003 | DE-627 | ||
| 005 | 20231225102242.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.semcancer.2019.08.017 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1001.xml |
| 035 | |a (DE-627)NLM300314949 | ||
| 035 | |a (NLM)31421263 | ||
| 035 | |a (PII)S1044-579X(19)30179-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tarasov, Vadim V |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Extracellular vesicles in cancer nanomedicine |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.03.2022 | ||
| 500 | |a Date Revised 03.03.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2019 Elsevier Ltd. All rights reserved. | ||
| 520 | |a To date, a lot of nanotechnological optitions are available for targeted drug delivery. Extracellular vesicles (EVs) are membrane structures that cells use for storage, transport, communication, and signaling. Recent research has focused on EVs as natural nanoparticles for drug delivery. This review sheds light on the application of EVs in cancer therapy, such as targeted chemotherapy, gene therapy, and vaccine development. Aspects of biogenesis, isolation, targeting, and loading of EVs are discussed in detail | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Cancer | |
| 650 | 4 | |a Exosomes | |
| 650 | 4 | |a Extracellular vesicles | |
| 650 | 4 | |a Nanodrug delivery | |
| 650 | 4 | |a Vaccines | |
| 650 | 7 | |a Antineoplastic Agents |2 NLM | |
| 700 | 1 | |a Svistunov, Andrey A |e verfasserin |4 aut | |
| 700 | 1 | |a Chubarev, Vladimir N |e verfasserin |4 aut | |
| 700 | 1 | |a Dostdar, Samira A |e verfasserin |4 aut | |
| 700 | 1 | |a Sokolov, Alexander V |e verfasserin |4 aut | |
| 700 | 1 | |a Brzecka, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Sukocheva, Olga |e verfasserin |4 aut | |
| 700 | 1 | |a Neganova, Margarita E |e verfasserin |4 aut | |
| 700 | 1 | |a Klochkov, Sergey G |e verfasserin |4 aut | |
| 700 | 1 | |a Somasundaram, Siva G |e verfasserin |4 aut | |
| 700 | 1 | |a Kirkland, Cecil E |e verfasserin |4 aut | |
| 700 | 1 | |a Aliev, Gjumrakch |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Seminars in cancer biology |d 1991 |g 69(2021) vom: 01. Feb., Seite 212-225 |w (DE-627)NLM012641944 |x 1096-3650 |7 nnns |
| 773 | 1 | 8 | |g volume:69 |g year:2021 |g day:01 |g month:02 |g pages:212-225 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.semcancer.2019.08.017 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 69 |j 2021 |b 01 |c 02 |h 212-225 | ||